Beneficial effects of MET-88, a gamma-butyrobetaine hydroxylase inhibitor in rats with heart failure following myocardial infarction
about
Protective effects of mildronate in an experimental model of type 2 diabetes in Goto-Kakizaki rats.Pharmacokinetics and pharmacodynamics of meldonium in exercised thoroughbred horses.Story behind meldonium-from pharmacology to performance enhancement: a narrative review.Fluoromethylated derivatives of carnitine biosynthesis intermediates--synthesis and applications.Mildronate treatment alters γ-butyrobetaine and l-carnitine concentrations in healthy volunteers.
P2860
Beneficial effects of MET-88, a gamma-butyrobetaine hydroxylase inhibitor in rats with heart failure following myocardial infarction
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Beneficial effects of MET-88, ...... ollowing myocardial infarction
@ast
Beneficial effects of MET-88, ...... ollowing myocardial infarction
@en
Beneficial effects of MET-88, ...... ollowing myocardial infarction
@nl
type
label
Beneficial effects of MET-88, ...... ollowing myocardial infarction
@ast
Beneficial effects of MET-88, ...... ollowing myocardial infarction
@en
Beneficial effects of MET-88, ...... ollowing myocardial infarction
@nl
prefLabel
Beneficial effects of MET-88, ...... ollowing myocardial infarction
@ast
Beneficial effects of MET-88, ...... ollowing myocardial infarction
@en
Beneficial effects of MET-88, ...... ollowing myocardial infarction
@nl
P2093
P1476
Beneficial effects of MET-88, ...... ollowing myocardial infarction
@en
P2093
N Matsuura
T Kirimoto
P304
P356
10.1016/S0014-2999(00)00098-4
P407
P577
2000-05-03T00:00:00Z